Gregory Gregoriadis
Präsident bei The International Liposome Society
Aktive Positionen von Gregory Gregoriadis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| The International Liposome Society | Präsident | 01.01.2003 | - |
Karriereverlauf von Gregory Gregoriadis
Ehemalige bekannte Positionen von Gregory Gregoriadis
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Xenetic Biosciences (UK) Ltd.
 Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 13.10.2009 | 10.02.2014 |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.1997 | 10.02.2014 | |
| Gründer | 13.10.2009 | 10.02.2014 | |
| University of London | Corporate Officer/Principal | - | - |
The Medical Research Council
 The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Corporate Officer/Principal | 17.11.2010 | - |
Ausbildung von Gregory Gregoriadis
| University of London | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 4 |
| Kanada | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Commercial Services | 3 |
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
The Medical Research Council
The Medical Research Council Miscellaneous Commercial ServicesCommercial Services The Medical Research Council provides human healthcare and social services. It offers funding for biomedical spectrum, fundamental lab-based science, clinical trials and all major disease areas. The company was founded in 1913 and is headquartered in Swindon, the United Kingdom. | Commercial Services |
Xenetic Biosciences (UK) Ltd.
Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Health Technology |
| The International Liposome Society | Commercial Services |
- Börse
- Insiders
- Gregory Gregoriadis
- Erfahrung